ZBTB24 regulates the apoptosis of human T cells via CDCA7/TRAIL-receptor axis

Weemaes, 2013, Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects, Eur. J. Hum. Genet., 21, 1219, 10.1038/ejhg.2013.40 Sterlin, 2016, Genetic, cellular and clinical features of ICF syndrome: a French National Survey, J. Clin. Immunol., 36, 149, 10.1007/s10875-016-0240-2 Hagleitner, 2008, Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome), J. Med. Genet., 45, 93, 10.1136/jmg.2007.053397 de Greef, 2011, Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2, Am. J. Hum. Genet., 88, 796, 10.1016/j.ajhg.2011.04.018 Thijssen, 2015, Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome, Nat. Commun., 6, 7870, 10.1038/ncomms8870 Jenness, 2018, HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome, Proc. Natl. Acad. Sci. U. S. A., 115, E876, 10.1073/pnas.1717509115 Thompson, 2018, ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation, Nucleic Acids Res., 46, 10034, 10.1093/nar/gky682 Maeda, 2016, Regulation of hematopoietic development by ZBTB transcription factors, Int. J. Hematol., 104, 310, 10.1007/s12185-016-2035-x Zhu, 2018, Regulation of the development and function of B cells by ZBTB transcription factors, Front. Immunol., 9, 580, 10.3389/fimmu.2018.00580 Wu, 2016, Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals, Hum. Mol. Genet., 25, 4041, 10.1093/hmg/ddw243 Blanco-Betancourt, 2004, Defective B-cell-negative selection and terminal differentiation in the ICF syndrome, Blood, 103, 2683, 10.1182/blood-2003-08-2632 Liang, 2016, Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells, Genes Immun., 17, 276, 10.1038/gene.2016.18 von Bernuth, 2014, Combined immunodeficiency develops with age in Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2), Orphanet J. Rare Dis., 9, 116, 10.1186/s13023-014-0116-6 Goto, 2006, JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity, Biochim. Biophys. Acta, 1759, 60, 10.1016/j.bbaexp.2006.02.004 Guiu, 2014, Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence, J. Exp. Med., 211, 2411, 10.1084/jem.20131857 Wang, 2003, TRAIL and apoptosis induction by TNF-family death receptors, Oncogene, 22, 8628, 10.1038/sj.onc.1207232 Martinez-Lorenzo, 1998, Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells, Eur. J. Immunol., 28, 2714, 10.1002/(SICI)1521-4141(199809)28:09<2714::AID-IMMU2714>3.0.CO;2-9 Diehl, 2004, TRAIL-R as a negative regulator of innate immune cell responses, Immunity, 21, 877, 10.1016/j.immuni.2004.11.008 Lehnert, 2014, TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation, J. Immunol., 193, 4021, 10.4049/jimmunol.1303242 Chyuan, 2018, TRAIL-mediated suppression of T cell receptor signaling inhibits T cell activation and inflammation in experimental autoimmune encephalomyelitis, Front. Immunol., 9, 15, 10.3389/fimmu.2018.00015 Liu, 2003, CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis, J. Clin. Investig., 112, 1332, 10.1172/JCI200319209 Cheng, 2016, Whole-Genome sequencing reveals diverse models of structural variations in esophageal squamous cell carcinoma, Am. J. Hum. Genet., 98, 256, 10.1016/j.ajhg.2015.12.013 Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinf., 12, 323, 10.1186/1471-2105-12-323 Anders, 2010, Differential expression analysis for sequence count data, Genome Biol., 11, R106, 10.1186/gb-2010-11-10-r106 Storey, 2003, Statistical significance for genomewide studies, Proc. Natl. Acad. Sci. U. S. A., 100, 9440, 10.1073/pnas.1530509100 Nitta, 2013, Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients, J. Hum. Genet., 58, 455, 10.1038/jhg.2013.56 Geiman, 2000, Lsh, an SNF2/helicase family member, is required for proliferation of mature T lymphocytes, Proc. Natl. Acad. Sci. U. S. A., 97, 4772, 10.1073/pnas.97.9.4772 Ueda, 2006, Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome, Development, 133, 1183, 10.1242/dev.02293 Unoki, 2019, CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome, J. Clin. Investig., 129, 78, 10.1172/JCI99751 Gatto, 2017, ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing, Nucleic Acids Res., 45, 5739, 10.1093/nar/gkx163